The relationship between the gene mutation of p53 and the protein expression of p53 and Ki-67 in non-Hodgkin's lymphomas

Pathology International

Volumn 46, Issue 2, 1996, Pages 130-136

  Kuze, Tetuo ^a,b   Nakamura, Naoya ^a   Hashimoto, Yuko ^a   Hojo, Hiroshi ^a   Abe, Masafumi ^a   Wakasa, Haruki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOA EIYO LTD   (Japan)

Author keywords

gene mutation; immunohistochemistry; Ki 67 proliferating fraction; non Hodgkin's lymphoma; p53

Indexed keywords

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CONTROLLED STUDY; DNA SEQUENCE; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHODGKIN LYMPHOMA; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; T CELL LYMPHOMA;

EID: 0029894042     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03588.x     Document Type: Article

References (31)

1. Isobe M, Emanuel B, Givol D, Oren M, Croce C. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986; 320: 84-85.
2. Finlay CA, Hinds PW, Levien AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093.
3. Danova M, Giordano M, Mazzini G, Riccardi A. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leukemia Res. 1990; 14: 417-422.
4. Mercer WD, Avignolo C, Baserga R. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol. Cell. Biol. 1984; 4: 276-281.
5. Milnei J. The role of p53 in normal control of cell proliferation. Curr. Cell Biol. 1991; 3: 282-286.
6. Hollistein M, Sidrnsky D, Vogelstein B, Harris CC. P53 mutation in human cancers. Science 1991; 253: 49-53.
7. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-456.
8. Nigro JM, Baker SJ, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705-708.
9. Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T. P53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 1991; 10: 2879-2887.
10. Fenaux P, Jonveaux P, Quiquandon I et al. Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: A report on 60 cases. Leukemia 1992; 6: 42-46.
11. Gaidano G, Ballerini P, Gong JZ et al. P53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl Acad. Sci. 1991; 88: 5413-5417.
12. Ichikawa A, Hotta T, Takagi N et al. Mutation of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 1992; 79: 2701-2707.
13. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R. P53 mutation are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289-2295.
14. Nakamura H, Said JW, Miller CW, Koeffler HP. Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. Blood 1993; 82: 920-926.
15. Villuendas R, Piris MA, Algara P et al. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 1993; 82: 3151-3156.
16. Wiman KG, Magnusson KP, Ramqvist T, Klein G. Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240. Oncogens 1991; 6: 1633-1639.
17. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 1988; 8: 531-539.
18. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-679.
19. Gerdes J, Schwab U, Lemke H, Baisch H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13-20.
20. Schwartz BR, Pinkus G, Bacus S, Toder M, Weinberg DS. Cell proliferation in non-Hodgkin's lymphomas: Digital image analysis of Ki-67 antibody staining. Am. J. Pathol. 1989; 134: 327-336.
21. Tominaga K, Yamaguchi Y, Nozawa Y, Abe M, Wakasa H. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67. Hematol. Oncol. 1992; 10: 163-169.
22. The non-Hodgkin's Lymphoma Pathologic Classification Project. National cancer institute sponsored study of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-2135.
23. Murakami Y, Hayashi K, Sekiya T. Detection of aberration of p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res. 1991; 51: 3356-3361.
24. Gyllensten UB, Erlich HA. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc. Natl Acad. Sci. USA 1988; 85: 7652-7656.
25. + anaplastic lymphomas. Hematol. Pathol. 1991; 5: 67-73.
26. Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP. Immunohistochemical analysis of p53 expression in malignant lymphoma. Am. J. Pathol. 1992; 141: 1343-1348.
27. Soini Y, Paakko P, Alavaikko M, Vahakangas K. P53 expression in lymphatic malignancies. J. Clin. Pathol. 1992; 45: 1011-1014.
28. Villuendas R, Piris MA, Orradre JL et al. P53 protein expression in lymphomas and reactive lymphoid tissue. J. Pathol. 1992; 166: 235-241.
29. Harris NL, Bhan AK. Distribution of T-cell subsets in follicular and diffuse lymphomas of B cell type. Am. J. Pathol. 1983; 113: 172-180.
30. Reich NC, Levine AJ. Growth regulation of cellular tumour antigen, p53, in nontransformed cells. Nature 1984; 308: 199-201.
31. Mercer WE, Baserga R. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocyte. Exp. Cell Res. 1985; 160: 31-46.